Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Relay Therapeutics (RLAY) Interest Expenses (2020 - 2023)

Historic Interest Expenses for Relay Therapeutics (RLAY) over the last 4 years, with Q1 2023 value amounting to $3000.0.

  • Relay Therapeutics' Interest Expenses fell 8571.43% to $3000.0 in Q1 2023 from the same period last year, while for Dec 2023 it was $3000.0, marking a year-over-year decrease of 8571.43%. This contributed to the annual value of $4000.0 for FY2021, which is 7500.0% down from last year.
  • Latest data reveals that Relay Therapeutics reported Interest Expenses of $3000.0 as of Q1 2023, which was down 8571.43% from $21000.0 recorded in Q1 2022.
  • In the past 5 years, Relay Therapeutics' Interest Expenses ranged from a high of $21000.0 in Q1 2022 and a low of $3000.0 during Q2 2020
  • Its 4-year average for Interest Expenses is $7500.0, with a median of $5000.0 in 2020.
  • In the last 5 years, Relay Therapeutics' Interest Expenses surged by 32000.0% in 2022 and then crashed by 8571.43% in 2023.
  • Quarter analysis of 4 years shows Relay Therapeutics' Interest Expenses stood at $8000.0 in 2020, then plummeted by 37.5% to $5000.0 in 2021, then soared by 320.0% to $21000.0 in 2022, then plummeted by 85.71% to $3000.0 in 2023.
  • Its Interest Expenses stands at $3000.0 for Q1 2023, versus $21000.0 for Q1 2022 and $5000.0 for Q1 2021.